The detection of significant changes in CSF NSE levels in both AD and DLB reminds us that AD and DLB share common amyloid β- and tau-related pathologies [35], but examining the effects of these pathologies on CSF NSE levels would require further studies, such as studies involving amyloid or tau PET. Here, MAPT is linked to Lewy body dementia.